TapewireFind a company

person · Reporting owner

Bichara Guillermo

Disclosed activity across 2 companies

Tapewire entity
61178
SEC CIK
0001629436

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
LINDE PLCLIN · Entity 2835Exec VP & Chief Legal OfficerMarch 10, 2026March 12, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LINDE PLC

Report date March 10, 2026 · Filed March 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect22,137.769 Reported balance After 2026-03-10 transaction · row 1
1 source row

Row 1 · 2026-03-10 · Sale · Disposed 4,357 · Balance 22,137.769

F1: Sales made under a 10b5-1 plan entered into on August 22, 2025.

Ordinary SharesSEC Table I · non-derivativeIndirect401(k)2,944.983 Reported balance Holding disclosure · report date 2026-03-10 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 2,944.983

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect1,830 Reported balance Holding disclosure · report date 2026-03-10 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance 1,830

F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect1,570 Reported balance Holding disclosure · report date 2026-03-10 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance 1,570

F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect1,613 Reported balance Holding disclosure · report date 2026-03-10 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance 1,613

F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $483.62 · Expires 2036-03-09Direct14,917 Reported balance Holding disclosure · report date 2026-03-10 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance 14,917

F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $468.77 · Expires 2035-03-07Direct11,326 Reported balance Holding disclosure · report date 2026-03-10 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance 11,326

F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07Direct10,345 Reported balance Holding disclosure · report date 2026-03-10 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance 10,345

F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07Direct11,085 Reported balance Holding disclosure · report date 2026-03-10 · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · Balance 11,085

F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $270.99 · Expires 2032-03-07Direct13,280 Reported balance Holding disclosure · report date 2026-03-10 · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · Balance 13,280

F10: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08Direct20,975 Reported balance Holding disclosure · report date 2026-03-10 · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · Balance 20,975

F11: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09Direct26,155 Reported balance Holding disclosure · report date 2026-03-10 · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · Balance 26,155

F12: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

Deferred Stock UnitsSEC Table II · derivative / convertible securityDirect852.647 Reported balance Holding disclosure · report date 2026-03-10 · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · Balance 852.647

F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

F13: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Sales made under a 10b5-1 plan entered into on August 22, 2025.

F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.

F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

F10: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

F11: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

F12: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

F13: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PRAXAIR INC

Report date October 31, 2018 · Filed November 02, 2018

Section 16 reporting ended · disclosed 2018-11-02. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirect401(k)0 Reported balance After 2018-10-31 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2018-10-31 · Disposition to issuer · Disposed 1,751.0307 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2018-10-31 transaction · row 2
1 source row

Row 2 · 2018-10-31 · Disposition to issuer · Disposed 2,944 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2018-10-31 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2018-10-31 · Disposition to issuer · Disposed 5,670 · Balance 0

F2: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2018-10-31 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2018-10-31 · Disposition to issuer · Disposed 3,174 · Balance 0

F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2018-10-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2018-10-31 · Disposition to issuer · Disposed 4,384 · Balance 0

F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2018-10-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2018-10-31 · Disposition to issuer · Disposed 3,246 · Balance 0

F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2018-10-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2018-10-31 · Disposition to issuer · Disposed 3,000 · Balance 0

F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $109.68 · Expires 2022-02-28Direct0 Reported balance After 2018-10-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2018-10-31 · Disposition to issuer · Disposed 2,560 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26Direct0 Reported balance After 2018-10-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2018-10-31 · Disposition to issuer · Disposed 4,860 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25Direct0 Reported balance After 2018-10-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2018-10-31 · Disposition to issuer · Disposed 7,465 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24Direct0 Reported balance After 2018-10-31 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2018-10-31 · Disposition to issuer · Disposed 21,190 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23Direct0 Reported balance After 2018-10-31 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2018-10-31 · Disposition to issuer · Disposed 44,665 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28Direct0 Reported balance After 2018-10-31 transaction · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · 2018-10-31 · Disposition to issuer · Disposed 40,100 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27Direct0 Reported balance After 2018-10-31 transaction · row 14 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 14 · 2018-10-31 · Disposition to issuer · Disposed 38,800 · Balance 0

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2018-10-31 transaction · row 15 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 15 · 2018-10-31 · Disposition to issuer · Disposed 251.307 · Balance 0

F9: Conversion to Praxair Common Stock is on a l-for-1 basis.

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F10: Deferred stock units ("DSUs") acquired by the reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F2: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F9: Conversion to Praxair Common Stock is on a l-for-1 basis.

F10: Deferred stock units ("DSUs") acquired by the reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 07, 2023 Filed Sep 11, 2023 13:11 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 26,316 $384.66 $10,122,712.56
Disclosure

SEC source: 0001062993-23-017888 · form4.xml · nonDerivative · entry 2

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,645

F1 · kind: Ordinary shares withheld to pay exercise price and taxes.

Read SEC document
September 07, 2023 Filed Sep 11, 2023 13:11 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 38,800 $154.00 $5,975,200.00
Disclosure

SEC source: 0001062993-23-017888 · form4.xml · nonDerivative · entry 1

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2023 Filed May 3, 2023 13:46 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionStock Options (right to buy) · Derivative 40,100 $0.00 Strike: $118.71 $0.00
Disclosure

SEC source: 0001062993-23-010012 · form4.xml · derivative · entry 14

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 40,100 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F10 · derivative.exercise_date: This option vested in full over three years in three consecutive equal annual installments beginning one year after the date of the grant.

Read SEC document
May 01, 2023 Filed May 3, 2023 13:46 UTC LINDE PLC LIN · Entity 2835 SaleOrdinary Shares 14,648 $371.55 $5,442,464.40
Disclosure

SEC source: 0001062993-23-010012 · form4.xml · nonDerivative · entry 3

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,161

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F3 · price: The price reported is the weighted average sale price. The sale prices ranged from $371.41 to $371.88. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2023 Filed May 3, 2023 13:46 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 25,452 $371.87 $9,464,835.24
Disclosure

SEC source: 0001062993-23-010012 · form4.xml · nonDerivative · entry 2

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,809

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F2 · shares: Ordinary shares withheld to pay exercise price and taxes.

Read SEC document
May 01, 2023 Filed May 3, 2023 13:46 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 40,100 $118.70 $4,759,870.00
Disclosure

SEC source: 0001062993-23-010012 · form4.xml · nonDerivative · entry 1

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,261

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionRestricted Stock Units · Derivative 2,150 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · derivative · entry 15

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F2 · derivative.exercise_price: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020.

F2 · derivative.exercise_date: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020.

F2 · derivative.expiration_date: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionPerformance Share Units · Derivative 3,490 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · derivative · entry 11

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,490 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F5 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F5 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F5 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 GrantPerformance Share Units · Derivative 3,490 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · derivative · entry 10

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,490

Underlying: Ordinary Shares · 3,490 shares

Expires not disclosed

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F5 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F5 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F5 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionPerformance Share Units · Derivative 6,450 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · derivative · entry 9

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F4 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F4 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F4 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 GrantPerformance Share Units · Derivative 6,450 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · derivative · entry 8

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,450

Underlying: Ordinary Shares · 6,450 shares

Expires not disclosed

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F4 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F4 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

F4 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 1,618 $345.92 $559,698.56
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · nonDerivative · entry 6

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,161

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F3 · shares: Shares of common stock withheld from the payout to cover tax withholdings.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 3,490 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · nonDerivative · entry 5

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F5 · shares: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 2,989 $345.92 $1,033,954.88
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · nonDerivative · entry 4

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,289

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F3 · shares: Shares of common stock withheld from the payout to cover tax withholdings.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 6,450 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · nonDerivative · entry 3

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,278

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F4 · shares: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 997 $345.92 $344,882.24
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · nonDerivative · entry 2

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,828

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F3 · shares: Shares of common stock withheld from the payout to cover tax withholdings.

Read SEC document
March 10, 2023 Filed Mar 13, 2023 11:59 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 2,150 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006687 · form4.xml · nonDerivative · entry 1

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,825

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F2 · shares: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 15:22 UTC LINDE PLC LIN · Entity 2835 GrantStock Options (right to buy) · Derivative 11,085 $0.00 Strike: $354.14 $0.00
Disclosure

SEC source: 0001062993-23-006404 · form4.xml · derivative · entry 7

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,085

Underlying: Ordinary Shares · 11,085 shares

Expires 2033-03-07

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F6 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 15:22 UTC LINDE PLC LIN · Entity 2835 GrantRestricted Stock Units · Derivative 1,680 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-006404 · form4.xml · derivative · entry 3

Bichara Guillermo · CIK 0001629436 · Exec VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680

Underlying: Ordinary Shares · 1,680 shares

Expires not disclosed

F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders.

F2 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

F2 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

F2 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
February 13, 2023 Filed Feb 15, 2023 16:11 UTC LINDE PLC LIN · Entity 2835 GrantDeferred Stock Units · Derivative 65.28 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-003655 · form4.xml · derivative · entry 12

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 721.894

Underlying: Ordinary Shares · 721.894 shares

Expires not disclosed

F10 · derivative.exercise_price: Conversion to Linde plc Ordinary Shares is on a one-to-one basis.

F11 · derivative.exercise_date: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

F11 · derivative.expiration_date: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionPerformance Share Units · Derivative 3,540 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · derivative · entry 12

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,540 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F5 · derivative.exercise_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F5 · derivative.expiration_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 GrantPerformance Share Units · Derivative 3,540 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · derivative · entry 11

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,540

Underlying: Ordinary Shares · 3,540 shares

Expires not disclosed

F5 · derivative.exercise_price: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F5 · derivative.exercise_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F5 · derivative.expiration_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionPerformance Share Units · Derivative 7,180 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · derivative · entry 10

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 7,180 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F4 · derivative.exercise_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F4 · derivative.expiration_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 GrantPerformance Share Units · Derivative 7,180 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · derivative · entry 9

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,180

Underlying: Ordinary Shares · 7,180 shares

Expires not disclosed

F4 · derivative.exercise_price: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F4 · derivative.exercise_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

F4 · derivative.expiration_date: The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionRestricted Stock Units · Derivative 2,395 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · derivative · entry 8

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,395 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 20, 2019.

F3 · derivative.exercise_date: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 20, 2019.

F3 · derivative.expiration_date: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 20, 2019.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 1,110 $311.66 $345,942.60
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · nonDerivative · entry 6

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,675

F2 · shares: Shares of common stock withheld from the payout to cover tax withholdings.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 2,395 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · nonDerivative · entry 5

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,785

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 20, 2019.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 1,641 $311.66 $511,434.06
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · nonDerivative · entry 4

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,390

F2 · shares: Shares of common stock withheld from the payout to cover tax withholdings.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 3,540 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · nonDerivative · entry 3

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on March 20, 2019 (the "PSU").

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Tax withholdingOrdinary Shares 3,328 $311.66 $1,037,204.48
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · nonDerivative · entry 2

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,491

F2 · shares: Shares of common stock withheld from the payout to cover tax withholdings.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 14:21 UTC LINDE PLC LIN · Entity 2835 Exercise / conversionOrdinary Shares 7,180 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-008399 · form4.xml · nonDerivative · entry 1

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,819

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares of common stock acquired pursuant to the payout of a performance share unit grant made on March 20, 2019 (the "PSU").

Read SEC document
March 07, 2022 Filed Mar 9, 2022 15:30 UTC LINDE PLC LIN · Entity 2835 GrantDeferred Stock Units · Derivative 64.25 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-007159 · form4.xml · derivative · entry 13

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 656.614

Underlying: Ordinary Shares · 656.614 shares

Expires not disclosed

F11 · derivative.exercise_price: Conversion to Linde plc Ordinary Shares is on a one-to-one basis.

F12 · derivative.exercise_date: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

F12 · derivative.expiration_date: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 15:30 UTC LINDE PLC LIN · Entity 2835 GrantStock Options (right to buy) · Derivative 13,280 $0.00 Strike: $270.99 $0.00
Disclosure

SEC source: 0001062993-22-007159 · form4.xml · derivative · entry 7

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,280

Underlying: Ordinary Shares · 13,280 shares

Expires 2032-03-07

F5 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 15:30 UTC LINDE PLC LIN · Entity 2835 GrantRestricted Stock Units · Derivative 1,535 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-007159 · form4.xml · derivative · entry 3

Bichara Guillermo · CIK 0001629436 · Senior VP& Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,535

Underlying: Ordinary Shares · 1,535 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

F1 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

F1 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerDeferred Stock Units · Derivative 251.307 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 15

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 251.307 shares

Expires not disclosed

F9 · derivative.exercise_price: Conversion to Praxair Common Stock is on a l-for-1 basis.

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F10 · derivative.exercise_date: Deferred stock units ("DSUs") acquired by the reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.

F10 · derivative.expiration_date: Deferred stock units ("DSUs") acquired by the reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerStock Option (right to buy) · Derivative 38,800 Not disclosed Strike: $154.00 Not disclosed
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 14

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,800 shares

Expires 2028-02-27

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F8 · price: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F8 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerStock Option (right to buy) · Derivative 40,100 Not disclosed Strike: $118.71 Not disclosed
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 13

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,100 shares

Expires 2027-02-28

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F7 · price: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F7 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerStock Option (right to buy) · Derivative 44,665 Not disclosed Strike: $102.22 Not disclosed
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 12

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 44,665 shares

Expires 2026-02-23

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F6 · price: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F6 · derivative.exercise_date: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerStock Option (right to buy) · Derivative 21,190 Not disclosed Strike: $128.38 Not disclosed
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 11

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,190 shares

Expires 2025-02-24

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerStock Option (right to buy) · Derivative 7,465 Not disclosed Strike: $128.80 Not disclosed
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 10

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,465 shares

Expires 2024-02-25

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerStock Option (right to buy) · Derivative 4,860 Not disclosed Strike: $110.58 Not disclosed
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 9

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,860 shares

Expires 2023-02-26

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerStock Option (right to buy) · Derivative 2,560 Not disclosed Strike: $109.68 Not disclosed
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 8

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,560 shares

Expires 2022-02-28

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerRestricted Stock Units · Derivative 3,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 7

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires not disclosed

F4 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F4 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F4 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerRestricted Stock Units · Derivative 3,246 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 6

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,246 shares

Expires not disclosed

F3 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F3 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F3 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerRestricted Stock Units · Derivative 4,384 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 5

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,384 shares

Expires not disclosed

F4 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F4 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F4 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerRestricted Stock Units · Derivative 3,174 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 4

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,174 shares

Expires not disclosed

F3 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F3 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F3 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerRestricted Stock Units · Derivative 5,670 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · derivative · entry 3

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,670 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F2 · derivative.exercise_date: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F2 · derivative.expiration_date: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerCommon Stock 2,944 $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · nonDerivative · entry 2

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F1 · price: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Read SEC document
October 31, 2018 Filed Nov 2, 2018 14:45 UTC PRAXAIR INC PX · Entity 162268 Disposition to issuerCommon Stock 1,751.0307 $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000081 · edgar.xml · nonDerivative · entry 1

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Indirect · 401(k)

Disclosed balance after: 0

F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F1 · price: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

Read SEC document
February 27, 2018 Filed Feb 28, 2018 21:53 UTC PRAXAIR INC PX · Entity 162268 GrantDeferred Stock · Derivative 73.871 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000884905-18-000021 · edgar.xml · derivative · entry 14

Bichara Guillermo · CIK 0001629436 · VP, General Counsel & Secty

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 247.382

Underlying: Common Stock · 73.871 shares

Expires not disclosed

F9 · derivative.exercise_price: Conversion to Praxair Common Stock is on a l-for-1 basis.

F10 · derivative.exercise_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock.

F10 · derivative.expiration_date: Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.